Azilsartan Kamedoxomil
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Azilsartan Kamedoxomil is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 25, 2011, and the first generic was approved Jul 20, 2022. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient.
Azilsartan Kamedoxomil is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.28 to $9.01 per EA — a 9% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.28 – $9.01
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Azurity Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin 2 Receptor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing AZILSARTAN KAMEDOXOMIL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EDARBI 80 MG TABLET | $9.0091 per EA | +0.05% |
EDARBI 40 MG TABLET | $8.2848 per EA | +0.02% |
Frequently Asked Questions
What is Azilsartan Kamedoxomil used to treat?
Azilsartan Kamedoxomil is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
When did Azilsartan Kamedoxomil become available as a generic?
FDA approved the first generic Azilsartan Kamedoxomil (ANDA) on Jul 20, 2022. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Azilsartan Kamedoxomil products are on the market?
The Azilsartan Kamedoxomil drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Azilsartan Kamedoxomil?
NADAC reference prices for Azilsartan Kamedoxomil range from $8.2848 to $9.0091 per EA — a 9% difference between cheapest and most expensive.
Which manufacturers make Azilsartan Kamedoxomil?
1 manufacturer lists Azilsartan Kamedoxomil in NADAC. Ranked by number of NDCs, the largest are Azurity Pharmaceuticals Inc. (2).
How has the price of Azilsartan Kamedoxomil changed recently?
Over the past 7 days, 2 Azilsartan Kamedoxomil NDCs rose and 0 fell, with a market-wide average change of +0.0%.